BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 35857529)

  • 1. Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines.
    Bowen JE; Addetia A; Dang HV; Stewart C; Brown JT; Sharkey WK; Sprouse KR; Walls AC; Mazzitelli IG; Logue JK; Franko NM; Czudnochowski N; Powell AE; Dellota E; Ahmed K; Ansari AS; Cameroni E; Gori A; Bandera A; Posavad CM; Dan JM; Zhang Z; Weiskopf D; Sette A; Crotty S; Iqbal NT; Corti D; Geffner J; Snell G; Grifantini R; Chu HY; Veesler D
    Science; 2022 Aug; 377(6608):890-894. PubMed ID: 35857529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection.
    Cao Y; Yisimayi A; Jian F; Song W; Xiao T; Wang L; Du S; Wang J; Li Q; Chen X; Yu Y; Wang P; Zhang Z; Liu P; An R; Hao X; Wang Y; Wang J; Feng R; Sun H; Zhao L; Zhang W; Zhao D; Zheng J; Yu L; Li C; Zhang N; Wang R; Niu X; Yang S; Song X; Chai Y; Hu Y; Shi Y; Zheng L; Li Z; Gu Q; Shao F; Huang W; Jin R; Shen Z; Wang Y; Wang X; Xiao J; Xie XS
    Nature; 2022 Aug; 608(7923):593-602. PubMed ID: 35714668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera.
    Muik A; Lui BG; Wallisch AK; Bacher M; Mühl J; Reinholz J; Ozhelvaci O; Beckmann N; Güimil Garcia RC; Poran A; Shpyro S; Finlayson A; Cai H; Yang Q; Swanson KA; Türeci Ö; Şahin U
    Science; 2022 Feb; 375(6581):678-680. PubMed ID: 35040667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients.
    Kawashiro K; Suzuki R; Nogimori T; Tsujino S; Iwahara N; Hirose T; Okada K; Yamamoto T; Fukuhara T; Hotta K; Shinohara N
    Sci Rep; 2024 May; 14(1):12176. PubMed ID: 38806644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies.
    Wang X; Zhao X; Song J; Wu J; Zhu Y; Li M; Cui Y; Chen Y; Yang L; Liu J; Zhu H; Jiang S; Wang P
    Emerg Microbes Infect; 2022 Dec; 11(1):477-481. PubMed ID: 35034583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines.
    Liang CY; Raju S; Liu Z; Li Y; Asthagiri Arunkumar G; Case JB; Scheaffer SM; Zost SJ; Acreman CM; Gagne M; Andrew SF; Carvalho Dos Anjos DC; Foulds KE; McLellan JS; Crowe JE; Douek DC; Whelan SPJ; Elbashir SM; Edwards DK; Diamond MS
    Nature; 2024 Jun; 630(8018):950-960. PubMed ID: 38749479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccines.
    Bowen JE; Sprouse KR; Walls AC; Mazzitelli IG; Logue JK; Franko NM; Ahmed K; Shariq A; Cameroni E; Gori A; Bandera A; Posavad CM; Dan JM; Zhang Z; Weiskopf D; Sette A; Crotty S; Iqbal NT; Corti D; Geffner J; Grifantini R; Chu HY; Veesler D
    bioRxiv; 2022 Mar; ():. PubMed ID: 35313570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bivalent vaccine containing D614G and BA.1 spike trimer proteins or a BA.1 spike trimer protein booster shows broad neutralizing immunity.
    Du P; Li N; Xiong X; Tang S; Dai Q; Liu Z; Wang T; Gu X; Zhou Z
    J Med Virol; 2022 Sep; 94(9):4287-4293. PubMed ID: 35614524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Bivalent Omicron-Containing Booster Vaccine against Covid-19.
    Chalkias S; Harper C; Vrbicky K; Walsh SR; Essink B; Brosz A; McGhee N; Tomassini JE; Chen X; Chang Y; Sutherland A; Montefiori DC; Girard B; Edwards DK; Feng J; Zhou H; Baden LR; Miller JM; Das R
    N Engl J Med; 2022 Oct; 387(14):1279-1291. PubMed ID: 36112399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants.
    Neerukonda SN; Wang R; Vassell R; Baha H; Lusvarghi S; Liu S; Wang T; Weiss CD; Wang W
    J Virol; 2022 Sep; 96(17):e0114022. PubMed ID: 36000843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant.
    Edara VV; Manning KE; Ellis M; Lai L; Moore KM; Foster SL; Floyd K; Davis-Gardner ME; Mantus G; Nyhoff LE; Bechnak S; Alaaeddine G; Naji A; Samaha H; Lee M; Bristow L; Gagne M; Roberts-Torres J; Henry AR; Godbole S; Grakoui A; Saxton M; Piantadosi A; Waggoner JJ; Douek DC; Rouphael N; Wrammert J; Suthar MS
    Cell Rep Med; 2022 Feb; 3(2):100529. PubMed ID: 35233550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential heterologous immunization with COVID-19 vaccines induces broader neutralizing responses against SARS-CoV-2 variants in comparison with homologous boosters.
    Shen X; Hao Y; Wang S; Li D; Ren L; Zhu M; Wang S; Li J; Tang W; Fu Y; Chen R; Liu Y; Shao Y
    Vaccine; 2023 Oct; 41(45):6645-6653. PubMed ID: 37770297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses in blood and saliva post COVID-19 bivalent booster do not reveal an Omicron BA.4/BA.5- specific response.
    Baker R; Lawlor R; Smith M; Price J; Eaton A; Lover A; Alfandari D; Reinhart P; Arcaro KF; Osborne BA
    Front Immunol; 2024; 15():1401209. PubMed ID: 38812500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone.
    da Silva ES; Kohnen M; Gilson G; Staub T; Arendt V; Hilger C; Servais JY; Charpentier E; Domingues O; Snoeck CJ; Ollert M; Seguin-Devaux C; Perez-Bercoff D
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imprinted antibody responses against SARS-CoV-2 Omicron sublineages.
    Park YJ; Pinto D; Walls AC; Liu Z; De Marco A; Benigni F; Zatta F; Silacci-Fregni C; Bassi J; Sprouse KR; Addetia A; Bowen JE; Stewart C; Giurdanella M; Saliba C; Guarino B; Schmid MA; Franko NM; Logue JK; Dang HV; Hauser K; di Iulio J; Rivera W; Schnell G; Rajesh A; Zhou J; Farhat N; Kaiser H; Montiel-Ruiz M; Noack J; Lempp FA; Janer J; Abdelnabi R; Maes P; Ferrari P; Ceschi A; Giannini O; de Melo GD; Kergoat L; Bourhy H; Neyts J; Soriaga L; Purcell LA; Snell G; Whelan SPJ; Lanzavecchia A; Virgin HW; Piccoli L; Chu HY; Pizzuto MS; Corti D; Veesler D
    Science; 2022 Nov; 378(6620):619-627. PubMed ID: 36264829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
    Weisblum Y; Schmidt F; Zhang F; DaSilva J; Poston D; Lorenzi JC; Muecksch F; Rutkowska M; Hoffmann HH; Michailidis E; Gaebler C; Agudelo M; Cho A; Wang Z; Gazumyan A; Cipolla M; Luchsinger L; Hillyer CD; Caskey M; Robbiani DF; Rice CM; Nussenzweig MC; Hatziioannou T; Bieniasz PD
    Elife; 2020 Oct; 9():. PubMed ID: 33112236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity.
    Muñoz-Alía MÁ; Nace RA; Balakrishnan B; Zhang L; Packiriswamy N; Singh G; Warang P; Mena I; Narjari R; Vandergaast R; Peng K-W; García-Sastre A; Schotsaert M; Russell SJ
    mBio; 2024 Feb; 15(2):e0292823. PubMed ID: 38193729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of Monovalent mRNA-1273 and BNT162b2 Vaccines in Children <5 Years of Age.
    Dalapati T; Williams CA; Giorgi EE; Hurst JH; Herbek S; Chen JL; Kosman C; Rotta AT; Turner NA; Pulido N; Aquino JN; Pfeiffer TS; Rodriguez J; Fouda GG; Permar SR; Kelly MS
    Pediatrics; 2024 Jun; 153(6):. PubMed ID: 38548700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional antibody responses targeting the Spike protein of SARS-CoV-2 Omicron XBB.1.5 in elderly nursing home residents following Wuhan-Hu-1-based mRNA booster vaccination.
    Sánchez-Simarro Á; Fernández-Soto D; Grau B; Albert E; Giménez E; Avilés-Alía AI; Gozalbo-Rovira R; Rusu L; Olea B; Geller R; Reyburn HT; Navarro D
    Sci Rep; 2024 May; 14(1):11896. PubMed ID: 38789475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost.
    Ai J; Zhang H; Zhang Y; Lin K; Zhang Y; Wu J; Wan Y; Huang Y; Song J; Fu Z; Wang H; Guo J; Jiang N; Fan M; Zhou Y; Zhao Y; Zhang Q; Liu Q; Lv J; Li P; Qiu C; Zhang W
    Emerg Microbes Infect; 2022 Dec; 11(1):337-343. PubMed ID: 34935594
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.